These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15168589)

  • 41. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.
    Shimada K; Yokozawa T; Atsuta Y; Kohno A; Maruyama F; Yano K; Taji H; Kitaori K; Goto S; Iida H; Morishima Y; Kodera Y; Naoe T; Morishita Y
    Bone Marrow Transplant; 2005 Jul; 36(2):115-21. PubMed ID: 15908969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Late effects of hematopoietic stem cell transplantation.
    Kansu E
    Hematology; 2005; 10 Suppl 1():238-44. PubMed ID: 16188682
    [No Abstract]   [Full Text] [Related]  

  • 43. Late effects of stem cell transplantation in brain tumor survivors.
    Danner-Koptik K; Jacobsohn DA; Dilley KJ
    Cancer Treat Res; 2009; 150():67-79. PubMed ID: 19834662
    [No Abstract]   [Full Text] [Related]  

  • 44. Secondary cancers following allogeneic haematopoietic cell transplantation in adults.
    Majhail NS
    Br J Haematol; 2011 Aug; 154(3):301-10. PubMed ID: 21615719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cutaneous Malignant Neoplasms in Hematopoietic Cell Transplant Recipients: A Systematic Review.
    DePry JL; Vyas R; Lazarus HM; Caimi PF; Gerstenblith MR; Bordeaux JS
    JAMA Dermatol; 2015 Jul; 151(7):775-82. PubMed ID: 25902409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
    Michelis FV; Kotchetkov R; Grunwald RM; Azeem A; Atenafu EG; Lipton JH; Loach D; Gupta V; Kuruvilla J; Kim DD; Viswabandya A; Deotare U; Messner HA
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):945-951. PubMed ID: 28254442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data.
    Poch Martell M; Hamad N; Shin E; Moon JH; Sohn SK; Uhm J; Michelis FV; Viswabandya A; Lipton JH; Messner HA; Kim DDH
    Eur J Haematol; 2017 Aug; 99(2):160-168. PubMed ID: 28449187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma.
    Howe R; Micallef IN; Inwards DJ; Ansell SM; Dewald GW; Dispenzieri A; Gastineau DA; Gertz MA; Geyer SM; Hanson CA; Lacy MQ; Tefferi A; Litzow MR
    Bone Marrow Transplant; 2003 Aug; 32(3):317-24. PubMed ID: 12858205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction.
    Zamora-Ortiz G; Velázquez-Sánchez-de-Cima S; Ponce-de-León S; Gutiérrez-Aguirre CH; Ruiz-Delgado GJ; Gomez-Almaguer D; Ruiz-Argüelles GJ
    Hematology; 2014 Dec; 19(8):435-40. PubMed ID: 24552480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. From Smoke to Smother: Secondary Sarcoma following Stem Cell Transplantation for Thalassemia.
    Haeuser S; Nissen J; Greil J; Duerken M; Karremann M
    Klin Padiatr; 2016 Nov; 228(6-07):339-340. PubMed ID: 27442142
    [No Abstract]   [Full Text] [Related]  

  • 53. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
    Friedberg JW
    Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
    [No Abstract]   [Full Text] [Related]  

  • 55. Increased incidence of fractures in recipients of hematopoietic stem-cell transplantation.
    Pundole XN; Barbo AG; Lin H; Champlin RE; Lu H
    J Clin Oncol; 2015 Apr; 33(12):1364-70. PubMed ID: 25779562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.
    Clavert A; Peric Z; Brissot E; Malard F; Guillaume T; Delaunay J; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Harousseau JL; Moreau P; Milpied N; Mohty M; Chevallier P
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):140-146. PubMed ID: 27751934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Late effects after hematopoietic stem cell transplantation--critical issues.
    Tichelli A; Rovó A; Socié G
    Curr Probl Dermatol; 2012; 43():132-49. PubMed ID: 22377926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The sources and uses of hematopoietic stem cells keep increasing.
    Trigg ME
    Del Med J; 1998 Sep; 70(9):387-92. PubMed ID: 9805406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse Late and Long-Term Treatment Effects in Adult Allogeneic Hematopoietic Stem Cell Transplant Survivors.
    Mosesso K
    Am J Nurs; 2015 Nov; 115(11):22-34; quiz 35. PubMed ID: 26473441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.